Item 8.01. Other Events.

In May 2021, Eli Lilly and Company ("Lilly") received a subpoena from the U.S. Department of Justice requesting the production of certain documents relating to its manufacturing site in Branchburg, New Jersey ("Branchburg"). Lilly is cooperating fully with the investigation.

Lilly had previously engaged external counsel to conduct an independent investigation of certain allegations relating to Branchburg. Lilly, through its counsel, is investigating these allegations thoroughly.

Lilly is deeply committed to manufacturing high-quality medicines for patients who need them, and the safety and quality of our products is our highest priority.

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses